Search for: "Pharmaceutical Manufacturing Research Services, Inc. v. FDA" Results 21 - 40 of 57
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Feb 2009, 5:00 am
(Patent Baristas) US: Teva releases second video in year of affordable healthcare campaign (SmartBrief) US: Discussion of NYT article ‘Crop Scientists Say Biotechnology Seed Companies are Thwarting Research’ (Patent Docs) (Patent Baristas) US FDA: Genetically engineered organisms can be patented (RelatIP) US: Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo seeks review and correction of patent term adjustment for patent covering ‘embolic… [read post]
25 Jan 2024, 5:31 am by Ashley Morgan
Crude oil contains metals such as Cadmium (Cd), Lead (Pb), Manganese (Mn), Nickel (Ni), and Vanadium (V). [read post]
11 Nov 2011, 11:55 am by Bexis
Connex-Metalna Management Consulting GmbH, 302 F.3d 358, 365 (5th Cir. 2002) (quoting United Parcel Service, Inc. v. [read post]
22 Mar 2011, 10:57 am by Kevin LaCroix
In particular the Court reiterated its prior statement of the standard for materiality in the   Basic, Inc. v. [read post]
31 Jul 2008, 5:30 pm
Because a manufacturer cannot be required to warn of a risk unknown to science, the knowledge chargeable to him must be limited to that of the period during which the plaintiff was using the product in question.Ortho Pharmaceutical Corp. v. [read post]
11 Jan 2008, 9:00 am
China is liable for copyright infringement because it provided search and linking services that directed users to sound recordings Yahoo! [read post]
14 Dec 2007, 1:00 am
Gore & Associates Inc. held to have willfully infringed rival C.R. [read post]
1 Mar 2013, 2:30 pm by Bexis
McNeil-PPC, Inc., 2009 WL 1178651, at *3-4 (Pa. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to… [read post]
29 Aug 2016, 1:19 pm by Michael Grossman
Both drugs are manufactured by Janssen Pharmaceutical, a subsidiary of the parent corporation Johnson & Johnson. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP)   Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt)     Events 26 August:… [read post]